Enlivex Therapeutics Ltd.

NASDAQ: ENLV · Real-Time Price · USD
1.82
0.04 (2.25%)
At close: Aug 15, 2025, 3:59 PM
1.91
4.95%
After-hours: Aug 15, 2025, 07:55 PM EDT

Enlivex Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.6 -1.73 -2.33 -7.72
PEG Ratio
0.03 0.05 -0.01 0.16
PS Ratio
n/a n/a n/a n/a
PB Ratio
1.02 1.67 1.28 1.31
P/FCF Ratio
-1.83 -2.11 -2.26 -5.82
P/OCF Ratio
-1.85 -2.13 -3.03 -6.36
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.02 0.03 0.09 0.01
Quick Ratio
6.84 5.57 7.74 20.91
Current Ratio
6.84 5.57 7.92 18.32
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a -2.1K -4.9 -58.8
Return on Equity
-0.64 -0.97 -0.55 -0.17
Return on Assets
-0.54 -0.79 -0.46 -0.15
Return on Invested Capital
-0.64 -0.94 -0.42 -0.21
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a